Hepatitis C virus therapeutics: at the end of the beginning.
作者信息
Schooley Robert T
出版信息
Top Antivir Med. 2012 Apr-May;20(1):17-9.
Abstract
摘要
相似文献
1
Hepatitis C virus therapeutics: at the end of the beginning.
Top Antivir Med. 2012 Apr-May;20(1):17-9.
2
Direct-acting antiviral treatment against hepatitis C virus infection in HIV-Infected patients - "En route for eradication"?
J Infect. 2017 Sep;75(3):234-241. doi: 10.1016/j.jinf.2017.05.008. Epub 2017 Jun 2.
3
Curing hepatitis C virus (HCV) after organ transplantation: Increased risk of rejection following HCV elimination.
Transpl Infect Dis. 2018 Feb;20(1). doi: 10.1111/tid.12796. Epub 2017 Nov 28.
4
Daclatasvir plasma concentration assessment in HIV-HCV-coinfected real-life patients.
Antivir Ther. 2017;22(8):731-733. doi: 10.3851/IMP3163.
5
Hepatitis C virus virology and new treatment targets.
Expert Rev Anti Infect Ther. 2009 Apr;7(3):329-50. doi: 10.1586/eri.09.12.
6
[Research progress of hepatitis C in 2018].
Zhonghua Gan Zang Bing Za Zhi. 2019 Jan 20;27(1):6-9. doi: 10.3760/cma.j.issn.1007-3418.2019.01.003.
7
[Effectiveness and safety of direct-acting antiviral agents for treatment of patients with chronic hepatitis C virus infection].
Zhonghua Gan Zang Bing Za Zhi. 2018 Mar 20;26(3):175-178. doi: 10.3760/cma.j.issn.1007-3418.2018.03.004.
8
Clinically Approved Ion Channel Inhibitors Close Gates for Hepatitis C Virus and Open Doors for Drug Repurposing in Infectious Viral Diseases.
J Virol. 2017 Jan 3;91(2). doi: 10.1128/JVI.01914-16. Print 2017 Jan 15.
9
Emerging antiviral drugs for hepatitis C virus.
Rev Recent Clin Trials. 2009 Sep;4(3):179-84. doi: 10.2174/157488709789957628.
10
New Treatments Have Changed the Game: Hepatitis C Treatment in Primary Care.
Infect Dis Clin North Am. 2018 Jun;32(2):313-322. doi: 10.1016/j.idc.2018.02.012.
引用本文的文献
1
Management of hepatitis C virus infection: the basics.
Top Antivir Med. 2012 Dec;20(5):154-61.
本文引用的文献
1
The increasing burden of mortality from viral hepatitis in the United States between 1999 and 2007.
Ann Intern Med. 2012 Feb 21;156(4):271-8. doi: 10.7326/0003-4819-156-4-201202210-00004.
2
Preliminary study of two antiviral agents for hepatitis C genotype 1.
N Engl J Med. 2012 Jan 19;366(3):216-24. doi: 10.1056/NEJMoa1104430.
3
Telaprevir for previously untreated chronic hepatitis C virus infection.
N Engl J Med. 2011 Jun 23;364(25):2405-16. doi: 10.1056/NEJMoa1012912.
4
Boceprevir for untreated chronic HCV genotype 1 infection.
N Engl J Med. 2011 Mar 31;364(13):1195-206. doi: 10.1056/NEJMoa1010494.
5
The survival benefits of AIDS treatment in the United States.
J Infect Dis. 2006 Jul 1;194(1):11-9. doi: 10.1086/505147. Epub 2006 Jun 1.
6
Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study Investigators.
N Engl J Med. 1998 Mar 26;338(13):853-60. doi: 10.1056/NEJM199803263381301.
Zotero 插件